Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study) von Pinto, C, Di Fabio, F, Siena, S, Cascinu, S, Rojas Llimpe, FL, Ceccarelli, C, Mutri, V, Giannetta, L, Giaquinta, S, Funaioli, C, Berardi, R, Longobardi, C, Piana, E, Martoni, AA

Volltext